Listed

Research Frontiers Inc: Form 10-Q for the period ended Jun 30, 2019

Filed with the SEC on Aug 8, 2019 and accepted by EDGAR at Aug 8, 2019, 16:01 ET.

Share

Market risk

As filed, 221 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The information required by Item 3 has been disclosed in Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. There has been no material change in the disclosure regarding market risk.

Controls and procedures

As filed, 2,661 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. We designed our disclosure controls and procedures to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officer, to allow timely decisions regarding required disclosure. Our chief executive officer and chief financial officer, with assistance from other members of our management, have reviewed the effectiveness of our disclosure controls and procedures as of June 30, 2019, and, based on their evaluation, have concluded that, because of the need to test a new control during 2019 over the determination of the method for accounting for warrants issued in connection with a registered offering of common stock, that our disclosure controls and procedures were not effective at the reasonable assurance level solely as a result of the material weakness in our internal control over financial reporting discussed below.

Changes in Internal Control Over Financial Reporting

In connection with the preparation of our consolidated financial statements as of and for the quarter ended September 30, 2018, we identified a material weakness in our internal control over financial reporting related to our controls over the method for accounting for warrants issued in connection with a registered offering of common stock. This control deficiency did not result in a material adjustment to our financial statements for the period ended September 30, 2018. Management implemented additional review controls of equity transactions that were considered operating effectively as of June 30, 2019.

Forward-Looking Statements

The information set forth in this Report and in all publicly disseminated information about the Company, including the narrative contained in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” above, includes “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the safe harbor created by that section. Readers are cautioned not to place undue reliance on these forward-looking statements as they speak only as of the date hereof and are not guaranteed.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2019-04-01 to 2019-06-30$314.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2019-01-01 to 2019-06-30$543.9kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2019-04-01 to 2019-06-30−$952.3kus-gaap:OperatingIncomeLoss
Operating income6 months2019-01-01 to 2019-06-30−$1.5mus-gaap:OperatingIncomeLoss
Net income3 months2019-04-01 to 2019-06-30−$1.4mus-gaap:NetIncomeLoss
Net income6 months2019-01-01 to 2019-06-30−$2.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-04-01 to 2019-06-30−$0.05us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2019-01-01 to 2019-06-30−$0.07us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2019-01-01 to 2019-06-30−$1.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-01-01 to 2019-06-30$63.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-06-30$7.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-06-30$8.2mus-gaap:AssetsCurrent
Total assetsAt period end2019-06-30$9.3mus-gaap:Assets
Current liabilitiesAt period end2019-06-30$294.0kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-06-30$1.2mus-gaap:Liabilities
Shareholders' equityAt period end2019-06-30$8.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-19-011896. Last ingested by Listed: Nov 5, 2026, 16:22 ET. Listed shows no prices and gives no investment advice.